Dr. Soujanya Sodavarapu, MD

Dr. Sodavarapu practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Sodavarapu's NPI, 1831470129, was assigned on August 31, 2011. Dr. Sodavarapu graduated from Osmania Medical College NTR UHS in 2008. Dr. Sodavarapu's California license number on file is A127562.

Dr. Sodavarapu's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Sodavarapu's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Sodavarapu is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Sodavarapu to 2 more hospitals and 3 medical groups, each named with a free account. Dr. Sodavarapu's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sodavarapu practices, 4 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Sodavarapu's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Sodavarapu is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Sodavarapu's licenses on file in 3 states: California, Oklahoma and Illinois.

CMS data shows 93 Medicare services from Dr. Sodavarapu across 3 procedure codes in 2024, for 45 Medicare patients. Medicare paid $11,581 for them. Every service was in an office.

CMS counts 45 Medicare patients who saw Dr. Sodavarapu in 2024. The largest group is 65 to 74, with 18 patients. 75% of them have high cholesterol, and 71% have high blood pressure. Their average risk score is 1.18, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sodavarapu's median patient age at 54, with 69% women.

In 2024, Dr. Sodavarapu wrote 193 Medicare Part D claims for 54 patients. 74% of them were for generic drugs. CMS names the drug for 79 of them, across 5 drugs with 11 or more claims each, at $146,675 in total drug cost. In 2023, CMS named 76 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Sodavarapu for performance year 2024, reported as part of a group. Dr. Sodavarapu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sodavarapu as offering telehealth.

Dmand AI links 7 papers to Dr. Sodavarapu, published from 2019 to 2022. 2020 was the busiest year, with 4. Dr. Sodavarapu has published most often in Cureus. Dr. Sodavarapu's most frequent co-authors are Megha Goyal, MD, Rajani Rudrangi, MD and Saiyed Ali, MD.

CMS Open Payments shows 18 general payments to Dr. Sodavarapu from 9 drug and device companies from 2019 to 2024. Food and beverage make up the largest share, 89% of the total. Amgen Inc. paid the most, $411.

Dr. Sodavarapu graduated from Osmania Medical College NTR UHS in 2008.

Dr. Sodavarapu is in network with 8 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.